SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Long Term Outcomes of Hyperbaric Oxygen Therapy in Post COVID Condition: Longitudinal Follow-up of a Randomized Controlled Trial | Amir HadannyView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Long COVID in People Living with and without HIV | Annukka AntarView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Diurnal and Stimulated Cortisol Levels in People with Long COVID | Annukka AntarView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Neuroinflammation in Long COVID as Assessed by [11C]PBR28 PET Correlates with Vascular Disease Measures | Michael VanelzakkerView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Outcomes of Treatment with Vagal Nerve Stimulation (VNS) in Long COVID: A Pilot Study | Ravindra GaneshView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Assessing the Impact of Post-covid Clinics on Downstream Healthcare Utilization for Long COVID Patients | Ravindra GaneshView Slideset
SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Assessing the Conditional Dependencies of Post-COVID Symptoms using Network Analysis | Elizabeth UptonView Slideset
KQKieran QuinnMD, PhD, FRCP(C)SlidesetCOVID-19Demystifying Long COVID North American Conference 2024Causal Inference, EHR, Longitudinal Analyses in Long COVID | Kieran Quinn, MD PhD FRCP(C)View Slideset
LSMLindsay S. McAlpineMDSlidesetCOVID-19Demystifying Long COVID North American Conference 2024Neuropathogenesis | Lindsay S. McAlpine, M.D.View Slideset
MPMichael PelusoMDSlidesetCOVID-19Demystifying Long COVID North American Conference 2024SARS-CoV-2 Virology, Persistence, and Inflammation | Michael Peluso, MDView Slideset
COCaroline O'LearyBA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPISlidesetOncologyPharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and ImmunotherapyManagement of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPIView Slideset
MJMarkus JörgerMD, PhD, ClinPharmSlidesetOncologyPharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and ImmunotherapyTherapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic? | Markus Jörger, MD, PhD, ClinPharmView Slideset
